PL89031B1 - - Google Patents
Download PDFInfo
- Publication number
- PL89031B1 PL89031B1 PL1972157754A PL15775472A PL89031B1 PL 89031 B1 PL89031 B1 PL 89031B1 PL 1972157754 A PL1972157754 A PL 1972157754A PL 15775472 A PL15775472 A PL 15775472A PL 89031 B1 PL89031 B1 PL 89031B1
- Authority
- PL
- Poland
- Prior art keywords
- radical
- formula
- dihydroisoquinolin
- amino
- hydrogen
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 11
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 7
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 125000000392 cycloalkenyl group Chemical group 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- 238000005903 acid hydrolysis reaction Methods 0.000 claims description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052794 bromium Inorganic materials 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- 239000012433 hydrogen halide Substances 0.000 claims description 2
- 229910000039 hydrogen halide Inorganic materials 0.000 claims description 2
- 229910052740 iodine Inorganic materials 0.000 claims description 2
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 1
- 150000002431 hydrogen Chemical group 0.000 claims 1
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- -1 alkyl radical Chemical class 0.000 description 32
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 150000003254 radicals Chemical class 0.000 description 6
- 241000700159 Rattus Species 0.000 description 5
- 238000009835 boiling Methods 0.000 description 5
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000012467 final product Substances 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 3
- 229920001525 carrageenan Polymers 0.000 description 3
- 235000010418 carrageenan Nutrition 0.000 description 3
- 235000017803 cinnamon Nutrition 0.000 description 3
- AVMHMVJVHYGDOO-NSCUHMNNSA-N (e)-1-bromobut-2-ene Chemical compound C\C=C\CBr AVMHMVJVHYGDOO-NSCUHMNNSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 125000005018 aryl alkenyl group Chemical group 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 230000001562 ulcerogenic effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- WOGITNXCNOTRLK-VOTSOKGWSA-N (e)-3-phenylprop-2-enoyl chloride Chemical compound ClC(=O)\C=C\C1=CC=CC=C1 WOGITNXCNOTRLK-VOTSOKGWSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- LOYZVRIHVZEDMW-UHFFFAOYSA-N 1-bromo-3-methylbut-2-ene Chemical compound CC(C)=CCBr LOYZVRIHVZEDMW-UHFFFAOYSA-N 0.000 description 1
- BOMIIKYVZJCFQV-UHFFFAOYSA-N 1h-isoquinolin-2-amine Chemical class C1=CC=C2C=CN(N)CC2=C1 BOMIIKYVZJCFQV-UHFFFAOYSA-N 0.000 description 1
- GSQUVIBWTKWASE-UHFFFAOYSA-N 2-amino-3,4-dihydroisoquinolin-1-one Chemical compound C1=CC=C2C(=O)N(N)CCC2=C1 GSQUVIBWTKWASE-UHFFFAOYSA-N 0.000 description 1
- PNGKZNMGLJJYEI-UHFFFAOYSA-N 2-amino-3,4-dihydroisoquinolin-1-one;hydrochloride Chemical compound Cl.C1=CC=C2C(=O)N(N)CCC2=C1 PNGKZNMGLJJYEI-UHFFFAOYSA-N 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- USEGQJLHQSTGHW-UHFFFAOYSA-N 3-bromo-2-methylprop-1-ene Chemical compound CC(=C)CBr USEGQJLHQSTGHW-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- FDGVDPVWSQIWOA-UHFFFAOYSA-N C=CCCN(C(CC1=CC=CC=C11)N)C1=O Chemical compound C=CCCN(C(CC1=CC=CC=C11)N)C1=O FDGVDPVWSQIWOA-UHFFFAOYSA-N 0.000 description 1
- FAVIVVUSBFYAQC-UHFFFAOYSA-N CC=CCC(CC1=CC=CC=C1C1=O)N1N Chemical compound CC=CCC(CC1=CC=CC=C1C1=O)N1N FAVIVVUSBFYAQC-UHFFFAOYSA-N 0.000 description 1
- PYXIXQHRVMVIND-UHFFFAOYSA-N CCC(C=CC)N(C(CC1=CC=CC=C11)N)C1=O Chemical compound CCC(C=CC)N(C(CC1=CC=CC=C11)N)C1=O PYXIXQHRVMVIND-UHFFFAOYSA-N 0.000 description 1
- KSDVEFRCMDGDKX-UHFFFAOYSA-N Cl.C(C#C)NN1C(C2=CC=CC=C2CC1)=O Chemical compound Cl.C(C#C)NN1C(C2=CC=CC=C2CC1)=O KSDVEFRCMDGDKX-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- YNTGJZXKPFSTKY-UHFFFAOYSA-N NC(CC1=CC=CC=C11)N(C2C=CCCC2)C1=O Chemical compound NC(CC1=CC=CC=C11)N(C2C=CCCC2)C1=O YNTGJZXKPFSTKY-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical group [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- RMRFFCXPLWYOOY-UHFFFAOYSA-N allyl radical Chemical compound [CH2]C=C RMRFFCXPLWYOOY-UHFFFAOYSA-N 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000001834 epinephrinelike Effects 0.000 description 1
- QUPDWYMUPZLYJZ-UHFFFAOYSA-N ethyl Chemical compound C[CH2] QUPDWYMUPZLYJZ-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- XGXLLJGLOMBYLY-UHFFFAOYSA-N n-(1-oxo-3,4-dihydroisoquinolin-2-yl)benzenesulfonamide Chemical compound C1CC2=CC=CC=C2C(=O)N1NS(=O)(=O)C1=CC=CC=C1 XGXLLJGLOMBYLY-UHFFFAOYSA-N 0.000 description 1
- 231100000926 not very toxic Toxicity 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 125000001844 prenyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 231100000816 toxic dose Toxicity 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT25549/72A IT1045206B (it) | 1972-06-12 | 1972-06-12 | Aminoisochinoline |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL89031B1 true PL89031B1 (en, 2012) | 1976-10-30 |
Family
ID=11217059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL1972157754A PL89031B1 (en, 2012) | 1972-06-12 | 1972-09-14 |
Country Status (17)
| Country | Link |
|---|---|
| JP (1) | JPS5037197B2 (en, 2012) |
| AR (1) | AR204388A1 (en, 2012) |
| AT (1) | AT325048B (en, 2012) |
| AU (1) | AU470823B2 (en, 2012) |
| BE (1) | BE788901R (en, 2012) |
| CH (2) | CH562802A5 (en, 2012) |
| DE (1) | DE2244832A1 (en, 2012) |
| ES (1) | ES408635A1 (en, 2012) |
| FI (1) | FI50974C (en, 2012) |
| FR (1) | FR2187329B2 (en, 2012) |
| GB (1) | GB1380682A (en, 2012) |
| HU (1) | HU165564B (en, 2012) |
| IT (1) | IT1045206B (en, 2012) |
| NL (1) | NL7214650A (en, 2012) |
| PL (1) | PL89031B1 (en, 2012) |
| SU (1) | SU444365A3 (en, 2012) |
| ZA (1) | ZA726158B (en, 2012) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3037984A (en) * | 1960-01-27 | 1962-06-05 | Lakeside Lab Inc | Derivatives of n-amino-1, 2, 3, 4-tetrahydroisoquinoline |
-
0
- BE BE788901D patent/BE788901R/xx active
-
1972
- 1972-01-01 AR AR244108A patent/AR204388A1/es active
- 1972-06-12 IT IT25549/72A patent/IT1045206B/it active
- 1972-09-07 GB GB4159372A patent/GB1380682A/en not_active Expired
- 1972-09-08 ZA ZA726158A patent/ZA726158B/xx unknown
- 1972-09-12 FI FI722500A patent/FI50974C/fi active
- 1972-09-13 DE DE2244832A patent/DE2244832A1/de active Pending
- 1972-09-14 PL PL1972157754A patent/PL89031B1/pl unknown
- 1972-09-15 HU HULE667A patent/HU165564B/hu unknown
- 1972-09-15 AT AT793572A patent/AT325048B/de not_active IP Right Cessation
- 1972-09-18 SU SU1830979A patent/SU444365A3/ru active
- 1972-09-18 AU AU46767/72A patent/AU470823B2/en not_active Expired
- 1972-10-02 CH CH1436172A patent/CH562802A5/xx not_active IP Right Cessation
- 1972-10-02 CH CH217174A patent/CH564535A5/xx not_active IP Right Cessation
- 1972-10-30 NL NL7214650A patent/NL7214650A/xx unknown
- 1972-11-08 JP JP47111339A patent/JPS5037197B2/ja not_active Expired
- 1972-11-16 ES ES408635A patent/ES408635A1/es not_active Expired
- 1972-12-21 FR FR7245729A patent/FR2187329B2/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| BE788901R (fr) | 1973-01-02 |
| FI50974B (en, 2012) | 1976-05-31 |
| AU470823B2 (en) | 1976-04-01 |
| AU4676772A (en) | 1974-03-28 |
| NL7214650A (en, 2012) | 1973-12-14 |
| FR2187329A2 (en, 2012) | 1974-01-18 |
| GB1380682A (en) | 1975-01-15 |
| FR2187329B2 (en, 2012) | 1976-03-05 |
| CH562802A5 (en, 2012) | 1975-06-13 |
| CH564535A5 (en, 2012) | 1975-07-31 |
| AT325048B (de) | 1975-09-25 |
| HU165564B (en, 2012) | 1974-09-28 |
| ZA726158B (en) | 1973-06-27 |
| DE2244832A1 (de) | 1974-01-10 |
| ES408635A1 (es) | 1975-10-16 |
| FI50974C (fi) | 1976-09-10 |
| JPS4930380A (en, 2012) | 1974-03-18 |
| AR204388A1 (es) | 1976-02-06 |
| IT1045206B (it) | 1980-05-10 |
| JPS5037197B2 (en, 2012) | 1975-12-01 |
| SU444365A3 (ru) | 1974-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1269980A (en) | Antianaphylactic and antibronchospastic n- benzhydryldiazacycloalkylalkananilides | |
| JPS6089474A (ja) | モルフイナン誘導体，その製造方法，及び該化合物を含有する抗腫瘍剤 | |
| US3936461A (en) | Substituted 4-benzylquinolines | |
| Goodson et al. | Diphenylethylamines. I. The Preparation of Tertiary Amines by the Grignard Reaction1, 2 | |
| CA1212380A (fr) | Procede de preparation de nouveaux derives de thieno (2,3-b) pyrrole | |
| US2541211A (en) | Tertiary-aminoalkyl-tetrahydrocarbazoles | |
| US1970656A (en) | Thiazole compound and process of producing the same | |
| SU635874A3 (ru) | Способ получени производных 1,5,10, 10а-тетрагидротиазоло /3,4-в/изохинолина или их оптических изомеров или кислотно-аддитивных солей | |
| SU474981A3 (ru) | Способ получени 9(1-замещенный-4пиперидилиден)-тиоксантенов или их солей | |
| US3378561A (en) | 1-beta-arylthioethyltetrahydro-isoquinolines | |
| JPS62230767A (ja) | アセトアミド誘導体、その製造方法およびその医薬への応用 | |
| CS195325B2 (en) | Method of producing 4-aminoalkoxy-2/2h/pyranones 3-substituted and 5,6-condensed | |
| US3073826A (en) | 3-pyrrolidylmethyl-4-quinazolones | |
| PL89031B1 (en, 2012) | ||
| JPS61502959A (ja) | ４↓−（イソキサゾリル）↓−チアゾ−ル↓−２↓−オキサミド酸誘導体 | |
| US4287348A (en) | Preparation of sulphoalkyl quaternary salts | |
| EP0026505B1 (en) | 7,8-substituted-1-phenyl-2,3,4,5-tetrahydro-1-h-3-benzazepines | |
| US3983126A (en) | Aryloxy pyridine carboxylic-4-acids | |
| US3954763A (en) | N-Metatrifluoromethylthiophenyl-piperazine | |
| SU880251A3 (ru) | Способ получени производных тиохромана или их солей | |
| JPS6229585A (ja) | エーテル化若しくはエステル化しうるジヒドロキシ基により位置２で置換された４―ｏｈキノリンカルボン酸の新規の誘導体、その製造方法、及び医薬としてのその使用 | |
| PL81176B1 (en, 2012) | ||
| JP2678758B2 (ja) | 新規なプロパン誘導体 | |
| DK145225B (da) | Analogifremgangsmaade til fremstilling af 1-(3-trimethoxyphenoxy-2-hydroxy-propyl)-4-phenyl-piperazinderivater eller syreadditionssalte deraf | |
| EP0058009A1 (en) | Novel benzanilide derivatives and pharmaceutical compositions containing them |